Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Dianthus Therapeutics (DNTH) Preferred Shares Issued (2017)

Dianthus Therapeutics has reported Preferred Shares Issued over the past 1 years, most recently at $2.0 million for Q3 2017.

  • Quarterly results put Preferred Shares Issued at $2.0 million for Q3 2017, changed N/A from a year ago — trailing twelve months through Sep 2018 was $2.0 million (changed N/A YoY), and the annual figure for FY2022 was $100.0 million, changed.
  • Preferred Shares Issued for Q3 2017 was $2.0 million at Dianthus Therapeutics, down from $54.3 million in the prior quarter.
  • Over the last five years, Preferred Shares Issued for DNTH hit a ceiling of $54.3 million in Q2 2017 and a floor of $2.0 million in Q3 2017.